Kintara Therapeutics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$8,501,000 over the previous period. Total operating expenses were $8,451,000.

Profit Margin

Kintara Therapeutics, Inc. (NASDAQ:KTRA): Profit margin
2015 0 -4.79M
2016 0 -8.86M
2017 0 -8.08M
2018 0 -11.13M
2019 0 -7.40M
2020 0 -10.10M
2021 0 -38.32M
2022 0 -22.61M
2023 0 -14.64M
2024 0 -8.50M

KTRA Income Statement (2015 – 2024)

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue
Revenue
0000000000
Cost of revenue
55K60K60K32K10K16.34K24.52K16.68K10.28K0
Gross profit
-55K-60K-60K-32K-10K-16.34K-24.52K-16.68K-10.28K0
Operating exp.
Research and development
2.66M9.31M15.17M11.81M3.63M3.66M7.13M5.00M3.36M2.55M
Selling and marketing
0000000000
Total operating expenses
8.45M14.79M22.68M21.57M8.14M8.39M11.17M8.32M6.21M4.72M
Operating income
-8.50M-14.80M-22.68M-21.66M-7.08M-8.68M-11.17M-8.55M-3.56M-4.72M
Other income (expenses), net
131K147K28K-16.63M-982K639.84K3.10K324.15K-2.65M376.88K
Income before tax
-8.50M-14.64M-22.66M-38.29M-9.12M-8.04M-11.13M-8.08M-8.86M-4.79M
Income tax expense
76K-147K-42K26K981.37K-639.84K-39.45K-477.67K5.30M69.28K
Net income
-8.50M-14.64M-22.61M-38.32M-10.10M-7.40M-11.13M-8.08M-8.86M-4.79M
Earnings per share
Basic EPS
-3.23-9.04-23.22-74.02-48.39-143.87-266.96-335.43-404.86-251.98
Diluted EPS
-3.23-8.62-23.22-74.02-48.39-143.87-266.96-335.43-404.86-251.98
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source